The Role of Sodium Glucose Cotransporter-2 Inhibitors in Atherosclerotic Cardiovascular Disease: A Narrative Review of Potential Mechanisms

Sodium glucose cotransporter 2 (SGLT2) inhibitors are a class of medication with broad cardiovascular benefits in those with type 2 diabetes, chronic kidney disease, and heart failure. These include reductions in major adverse cardiac events and cardiovascular death. The mechanisms that underlie the...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Jennifer Y. Barraclough, Sanjay Patel, Jie Yu, Bruce Neal, Clare Arnott
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	MDPI AG 2021-10-01
Edice:	Cells
Témata:	sodium glucose cotransporter 2 inhibitor atherosclerosis cardiovascular disease inflammation mechanism of action
On-line přístup:	https://www.mdpi.com/2073-4409/10/10/2699
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!